← All organizations

Aragon Pharmaceuticals

For profitContributed to NME

Also known as: Aragon Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 3, 2018

Acquired by Johnson and Johnson on Jan 1, 2013

Timeline

2000s

Jan 1, 2009
Aragon Pharmaceuticals— Founded

2010s

Jan 1, 2013
Johnson and Johnson— Acquired By

Drugs by trial phase (17 distinct, 17 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (10 own, 0 via acquisition)

Indications

Studied for

Recent trials (24)

NCT03523338Lead sponsorPhase 3Jul 3, 2018
NCT03523338Study directorPhase 3Jul 3, 2018
NCT02592317Lead sponsorPhase 1Feb 12, 2016
NCT02578797Lead sponsorPhase 1Dec 18, 2015
NCT02489318Lead sponsorPhase 3Nov 27, 2015
NCT02531516Study directorPhase 3Nov 19, 2015
NCT02531516Lead sponsorPhase 3Nov 19, 2015
NCT02524717Lead sponsorPhase 1Aug 13, 2015
NCT02257736Lead sponsorPhase 3Nov 1, 2014
NCT02230033Lead sponsorPhase 1Sep 1, 2014
NCT02123758Lead sponsorPhase 1Jul 9, 2014
NCT02123758Study directorPhase 1Jul 9, 2014
NCT02160756Lead sponsorPhase 1Jun 1, 2014
NCT02106507CollaboratorPhase 1Apr 1, 2014
NCT02031666Lead sponsorPhase 1Dec 1, 2013

Details

Founded: San Diego, CA, US Jan 1, 2009
Last known activity: Jul 3, 2018